Kristin Brooks02.26.14
Patrick Bennett has been appointed executive director of lab operations for PPD’s new biomarker services division of its bioanalytical lab. PPD’s bioanalytical labs facilities in Richmond, VA, and Middleton, WI, provide customized biomarker measurement, comprehensive assay development, method development, validation, transfer and sample analysis, validated methods to quantitatively measure all types of compounds, chromatography, immunochemistry, and metabolite identification.
Mr. Bennett joins the company from Thermo Fisher Scientific, where he served as global strategic marketing director for pharma/biopharma life sciences mass spectrometry, and led efforts to develop, manage and implement marketing strategies. Prior to that, he served as vice president of business development and marketing and executive lab director at Tandem Labs, where he managed scientific and regulatory leadership activities.
“Patrick brings more than 25 years of experience in laboratories and biomarker services,” said David Johnston, Ph.D., PPD’s executive vice president of global laboratory services. “At PPD, our bioanalytical labs provide state-of-the-art facilities and instrumentation, scientific expertise, experienced regulatory staff and capabilities in a wide variety of technologies and methods. Patrick will lead and drive strategy for comprehensive biomarker development and testing from discovery through approval of predictive medicine biomarkers for both large and small molecule therapeutics.”
Mr. Bennett joins the company from Thermo Fisher Scientific, where he served as global strategic marketing director for pharma/biopharma life sciences mass spectrometry, and led efforts to develop, manage and implement marketing strategies. Prior to that, he served as vice president of business development and marketing and executive lab director at Tandem Labs, where he managed scientific and regulatory leadership activities.
“Patrick brings more than 25 years of experience in laboratories and biomarker services,” said David Johnston, Ph.D., PPD’s executive vice president of global laboratory services. “At PPD, our bioanalytical labs provide state-of-the-art facilities and instrumentation, scientific expertise, experienced regulatory staff and capabilities in a wide variety of technologies and methods. Patrick will lead and drive strategy for comprehensive biomarker development and testing from discovery through approval of predictive medicine biomarkers for both large and small molecule therapeutics.”